Analystreport

Verona Pharma plc (NASDAQ: VRNA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time